Rising biotech innovations to address Indonesia’s healthcare problems
With an over 270 million population, Indonesia remains an emerging medical market, supported by the surge of healthcare awareness demanded by the rising middle-income community. However, the country has faced chronic problems as the pandemic unveils shortcomings and an elevated sense of urgency to develop a more resilient healthcare system and innovations.
Being working moms: balancing motherhood and career
The first session of East Ventures' initial Women with Impact Forum on 16 February 2022, invited East Ventures’ Venture Partner, Avina Sugiarto; Mindtera’s Co-Founder and CEO, Tita Ardiati; and Nusantics’ Co-Founder and CEO, Sharlini Eriza Putri. It is moderated by East Ventures’ Senior Investment Associate, Stacy Oentoro.
East Ventures presents its first women-centered forum, Women with Impact Forum
East Ventures, a pioneering and leading sector-agnostic venture capital firm in Indonesia, today presented its first women-centered forum, named Women with Impact Forum. The forum provided the participants with three main sessions featuring several top key panelists from East Ventures and tech startup leaders. They shared their views and experiences towards women-related issues.
East Ventures Doubles Down on Nusantics
East Ventures Doubles Down on Nusantics 7 January, 2021 Nusantics, a genomics technology company, announced today that it has raised an undisclosed amount in Series A funding led by East Ventures. The startup also welcomed Triawan Munaf as a commissioner. East Ventures doubled down on Nusantics by leading a follow-up round less than a year after the VC firm led the biotech startup’s seed funding round. The fresh funding is a fruit of Nusantics’ strong growth and its swift response to the disruptions brought on by the COVID-19 pandemic. While staying focused on their microbiome [...]
Indonesia PASTI BISA disbursed IDR 5 billion
Indonesia PASTI BISA disbursed IDR 5 billion to procure raw materials for the production of 50.000 COVID-19 qPCR test kit 7 April 2020 JAKARTA, April 7, 2020 — Indonesia PASTI BISA, a collaborative movement initiated by East Ventures to support effort in fight against COVID-19, disbursed IDR 5 billion to purchase raw materials for the production of 50,000 COVID-19 qPCR test kits Indonesia PASTI BISA is raising fund with a target of Rp 10 billion to support TFRIC19, task force formed by the Agency for Assessment and Application of Technology (BPPT) to fight against COVID-19. [...]
Nusantics completed a COVID-19 qPCR test kit design prototype
Nusantics completed a COVID-19 qPCR test kit design prototype 4 April 2020 JAKARTA, 4 April 2020 – Nusantics has finished a design prototype of qPCR diagnostic that can specifically detect SARS-CoV-2 virus. The design process and laboratory testing of the test kit, named NUSANTARA TFRIC-19, was completed on Friday (3/4). Nusantics develop the test kit as a member of COVID-19 Research and Technology Innovation Task Force (TFRIC19) that formed by Indonesia Technology Assessment and Application Agency (BPPT). CTO of Nusantics Revata Utama explained that Nusantics designed the NUSANTARA TFRIC-19 using genomic data from the SARS-CoV-2 Asia [...]
East Ventures supporting development of COVID-19 test kits
East Ventures initiates Indonesia Pasti Bisa, supporting development and production of 100,000 COVID-19 test kits 27th March 2020 JAKARTA, 27th March 2020 — Since the finding of the first two cases of COVID-19 in early March, the spread of the SARS-CoV-2 virus keeps growing in Indonesia. Today, almost 900 cases of infection announced. One of the biggest obstacles met by Indonesia to contain the spread of the COVID-19 is test kits availability. Limited numbers of test kits available in the nation making it difficult for Indonesia to aggressively trace the spread of the virus, a [...]
Nusantics raised seed funding from East Ventures
Nusantics is a technology company that focuses on applying advancements in genomics and microbiome research to fulfill consumer needs of a healthy yet sustainable lifestyle.